Alternate Antibiotics for Skin Infection When Cephalexin Cannot Be Used
For uncomplicated skin infections in adults who cannot take cephalexin, use dicloxacillin 250-500 mg orally every 6 hours or clindamycin 300-450 mg orally every 6 hours for 5 days, extending only if symptoms have not improved. 1, 2
First-Line Alternatives Based on Allergy Type
For True Penicillin/Cephalosporin Allergy (Non-Anaphylactic)
- Clindamycin 300-450 mg orally every 6 hours is the optimal single-agent choice because it covers both streptococci and MRSA without requiring combination therapy 2, 3
- Use clindamycin only if local MRSA clindamycin resistance rates are <10%—this is a critical threshold that determines appropriateness 2, 3
- Clindamycin achieves 90-97% cure rates for uncomplicated skin infections and provides excellent coverage against the primary pathogens: beta-hemolytic streptococci and Staphylococcus aureus 2, 4
For Patients Who Can Tolerate Other Beta-Lactams
- Dicloxacillin 250-500 mg every 6 hours provides excellent streptococcal and MSSA coverage and is comparable to cephalexin in efficacy 1, 2, 5
- Amoxicillin 500 mg three times daily is appropriate for typical nonpurulent cellulitis, as beta-lactam monotherapy achieves 96% clinical success 2
- Amoxicillin-clavulanate 875/125 mg twice daily offers broader coverage and is particularly useful for bite-related infections 2
Treatment Duration and Monitoring
- Treat for exactly 5 days if clinical improvement occurs—this is supported by high-quality randomized controlled trial evidence showing no difference compared to 10-day courses 2
- Extend treatment only if warmth, tenderness, or erythema have not improved within the initial 5-day period 2
- Traditional 7-14 day courses are no longer necessary for uncomplicated cases and represent overtreatment 2
When to Add MRSA Coverage
Add MRSA-active antibiotics only when specific risk factors are present:
- Penetrating trauma or injection drug use 2
- Purulent drainage or exudate visible on examination 2
- Known MRSA colonization or prior MRSA infection 2
- Systemic inflammatory response syndrome (SIRS) 2
- Failure to respond to beta-lactam therapy after 48-72 hours 2
For purulent cellulitis requiring MRSA coverage:
- Clindamycin 300-450 mg every 6 hours as monotherapy (if local resistance <10%) 2, 3
- OR Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily PLUS a beta-lactam (amoxicillin or dicloxacillin) 2
- OR Doxycycline 100 mg twice daily PLUS a beta-lactam 2
Critical Caveats
Do NOT Use These as Monotherapy for Typical Cellulitis:
- Doxycycline alone—lacks reliable activity against beta-hemolytic streptococci, which cause ~96% of typical cellulitis cases 2
- Trimethoprim-sulfamethoxazole alone—inadequate streptococcal coverage and intrinsic resistance possible 2
- Fluoroquinolones (levofloxacin, moxifloxacin)—should be reserved for patients with beta-lactam allergies; lack adequate MRSA coverage 2
Cross-Reactivity Considerations:
- Cross-reactivity between penicillins and cephalosporins is only 2-4%, primarily based on R1 side chain similarity 2
- Cephalexin shares identical R1 side chains with amoxicillin, so avoid cephalexin in patients with confirmed immediate-type amoxicillin allergy 2
- For patients with anaphylaxis, angioedema, or urticaria to penicillins, do not use any cephalosporin 1
Essential Adjunctive Measures
- Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage 2
- Examine interdigital toe spaces for tinea pedis, fissuring, or maceration and treat to reduce recurrence 2
- Address underlying venous insufficiency, lymphedema, and chronic edema as part of routine care 2
When to Hospitalize
Admit for IV antibiotics if any of the following are present:
- Systemic inflammatory response syndrome (fever >38°C, tachycardia >90 bpm, tachypnea >24 rpm) 2
- Hypotension or hemodynamic instability 2
- Altered mental status or confusion 2
- Severe immunocompromise or neutropenia 2
- Concern for necrotizing infection (severe pain out of proportion, rapid progression, "wooden-hard" tissues) 2
For hospitalized patients: Vancomycin 15-20 mg/kg IV every 8-12 hours is first-line (A-I evidence), with alternatives including linezolid 600 mg IV twice daily or daptomycin 4 mg/kg IV once daily 2